Related references
Note: Only part of the references are listed.Fluid biomarkers in frontotemporal dementia: past, present and future
Imogen Joanna Swift et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)
New directions in clinical trials for frontotemporal lobar degeneration: Methods and outcome measures
Adam L. Boxer et al.
ALZHEIMERS & DEMENTIA (2020)
Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia
Carolin Heller et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2020)
Plasma sex hormone-binding globulin predicts neurodegeneration and clinical progression in prodromal Alzheimer's disease
Wei Xu et al.
Aging-US (2020)
Neurotoxic microglia promote TDP-43 proteinopathy in progranulin deficiency
Jiasheng Zhang et al.
NATURE (2020)
C9orf72 poly(GR) aggregation induces TDP-43 proteinopathy
Casey N. Cook et al.
SCIENCE TRANSLATIONAL MEDICINE (2020)
Blood-based biomarkers in hypothalamic-pituitary axes for the risk of dementia or cognitive decline: a systematic review and meta-analysis
Yi-Jun Ge et al.
AGING-US (2020)
A 2-Step Cerebrospinal Algorithm for the Selection of Frontotemporal Lobar Degeneration Subtypes
Alberto Lleo et al.
JAMA NEUROLOGY (2018)
Hypothalamic Alterations in Neurodegenerative Diseases and Their Relation to Abnormal Energy Metabolism
Pauline Vercruysse et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)
Novel CSF biomarkers to discriminate FTLD and its pathological subtypes
Marta del Campo et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2018)
Serum SHBG Levels are not Associated with Longitudinal Cognitive Decline in Mild Cognitive Impairment
Katherine Amy Lin et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Ante Mortem Cerebrospinal Fluid Tau Levels Correlate With Postmortem Tau Pathology in Frontotemporal Lobar Degeneration
David J. Irwin et al.
ANNALS OF NEUROLOGY (2017)
Testosterone, Estradiol, and Sex Hormone-Binding Globulin in Alzheimer's Disease: A Meta-Analysis
Jing Xu et al.
CURRENT ALZHEIMER RESEARCH (2016)
Metabolic and Non-Cognitive Manifestations of Alzheimer's Disease: The Hypothalamus as Both Culprit and Target of Pathology
Makoto Ishii et al.
CELL METABOLISM (2015)
Facilitating the validation of novel protein biomarkers for dementia: an optimal workflow for the development of sandwich immunoassays
Marta del Campo et al.
FRONTIERS IN NEUROLOGY (2015)
Sex Hormones Regulate Cytoskeletal Proteins Involved in Brain Plasticity
Valeria Hansberg-Pastor et al.
FRONTIERS IN PSYCHIATRY (2015)
Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine
David J. Irwin et al.
ACTA NEUROPATHOLOGICA (2015)
Reduced CSF p-Tau181 to Tau ratio is a biomarker for FTLD-TDP
William T. Hu et al.
NEUROLOGY (2013)
Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update
Marta del Campo et al.
BIOMARKERS IN MEDICINE (2012)
Eating and Hypothalamus Changes in Behavioral-Variant Frontotemporal Dementia
Olivier Piguet et al.
ANNALS OF NEUROLOGY (2011)
Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia
Katya Rascovsky et al.
BRAIN (2011)
Mild dementia is associated with increased adrenal secretion of cortisol and precursor sex steroids in women
Per Johansson et al.
CLINICAL ENDOCRINOLOGY (2011)
Elevated sex-hormone binding globulin in elderly women with Alzheimer's disease
EK Hoskin et al.
NEUROBIOLOGY OF AGING (2004)
Share Paper
